Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 31, 2023
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
Andrew Cooper Maintained (CDNA) at Strong Buy with Decreased Target to $24 on, Jan 31st, 2023
Andrew Cooper of Raymond James, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Decreased Target from $26 to $24 on, Jan 31st, 2023.
Andrew has made no other calls on CDNA in the last 4 months.
There are 2 other peers that have a rating on CDNA. Out of the 2 peers that are also analyzing CDNA, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $28 on, Monday, November 7th, 2022
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $40 on, Friday, November 4th, 2022
